3 Cancer Stocks Given a Lift by Amgen

Amgen's announcement also pushed up shares of companies developing similar new drug candidates. Mirati Therapeutics (NASDAQ:MRTX), Array Biopharma (NASDAQ:ARRY), and Gilead Sciences (NASDAQ:GILD) all rose a few percentage points following Amgen's announcement. Here's why the candidates they're developing could give these three stocks a big boost.